CapsoVision Inc
CV4.960USD
+0.090+1.85%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
232.12MMarket Cap
LossP/E TTM
More Details of CapsoVision Inc Company
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
CapsoVision Inc Info
Ticker SymbolCV
Company nameCapsoVision Inc
IPO dateJul 02, 2025
CEOWang (Kang-Huai)
Number of employees90
Security typeOrdinary Share
Fiscal year-endJul 02
Address18805 Cox Avenue
CitySARATOGA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95070
Phone14086241488
Websitehttps://www.capsovision.com/
Ticker SymbolCV
IPO dateJul 02, 2025
CEOWang (Kang-Huai)
Company Executives of CapsoVision Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.10M
+1104004.00%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.34K
+2887.00%
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
44.31K
+2887.00%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
23.60K
+2887.00%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.89K
+2887.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
--
--
Dr. Joanne Imperial, M.D.
Dr. Joanne Imperial, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Min-Liang Chen
Mr. Min-Liang Chen
Director
Director
--
--
Mr. Eliyahou Harari
Mr. Eliyahou Harari
Director
Director
--
--
Mr. Howard Lee
Mr. Howard Lee
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.10M
+1104004.00%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.34K
+2887.00%
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
44.31K
+2887.00%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
23.60K
+2887.00%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.89K
+2887.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
By BusinessUSD
Name
Revenue
Proportion
Products (capsules and capsule reading devices)
3.30M
93.39%
Services (cloud-based video delivery and reading services)
234.00K
6.61%
By RegionUSD
Name
Revenue
Proportion
United States
2.75M
77.70%
Outside United States
789.00K
22.30%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Products (capsules and capsule reading devices)
3.30M
93.39%
Services (cloud-based video delivery and reading services)
234.00K
6.61%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Harari Eliyahou Et Al
9.19%
Ching-Hang (Shen)
8.52%
Kioxia Corporation
7.36%
CID Greater China Venture Capital Fund III, L.P.
6.67%
Shih-Chang (Stephen Wu)
5.04%
Other
63.22%
Shareholders
Shareholders
Proportion
Harari Eliyahou Et Al
9.19%
Ching-Hang (Shen)
8.52%
Kioxia Corporation
7.36%
CID Greater China Venture Capital Fund III, L.P.
6.67%
Shih-Chang (Stephen Wu)
5.04%
Other
63.22%
Shareholder Types
Shareholders
Proportion
Individual Investor
17.61%
Corporation
14.03%
Other Insider Investor
9.19%
Investment Advisor
0.51%
Investment Advisor/Hedge Fund
0.42%
Hedge Fund
0.06%
Research Firm
0.02%
Pension Fund
0.02%
Bank and Trust
0.01%
Other
58.14%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
37
408.58K
0.06%
--
2025Q4
39
481.31K
1.03%
+382.93K
2025Q3
11
196.14K
0.42%
+171.24K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Harari Eliyahou Et Al
4.31M
9.19%
+4.31M
--
Jul 02, 2025
Ching-Hang (Shen)
3.99M
8.52%
+81.00K
+2.07%
Oct 01, 2025
Kioxia Corporation
3.45M
7.36%
+3.45M
--
Jul 02, 2025
CID Greater China Venture Capital Fund III, L.P.
3.13M
6.67%
-1.00
-0.00%
Sep 30, 2025
Shih-Chang (Stephen Wu)
2.36M
5.04%
+2.36M
--
Jul 02, 2025
Wang (Kang-Huai)
1.10M
2.36%
+1.10M
--
Jul 03, 2025
Harari (Michele)
576.80K
1.23%
+2.89K
+0.50%
Dec 31, 2025
The Vanguard Group, Inc.
69.58K
0.15%
+69.58K
--
Sep 30, 2025
Tsai (Chen Lung)
118.34K
0.25%
+2.89K
+2.50%
Dec 31, 2025
Geode Capital Management, L.L.C.
115.03K
0.25%
+90.13K
+361.98%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
